Mechanism of decreased transport of nitrogen mustard ( H N , ) in HN,-resistant Yorhida sarcoma cells was investigated. H N , uptake by Yoshida sarcoma cells proved to be temperature sensitive, saturable, affected by metabolic inhibitors, and also repressed competitively by choline chloride. In resi
Mechanism of resistance of yoshida sarcoma to nitrogen mustard
β Scribed by Makoto Inaba; Yoshio Sakurai
- Publisher
- John Wiley and Sons
- Year
- 1971
- Tongue
- French
- Weight
- 449 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Uptake and binding of methylβbis(2βchloroethyl)amine hydrochloride (HN~2~) to the cells of Yoshida sarcoma during their acquisition of resistance to this drug was investigated. With the increase of resistance index, drug uptake by the cells decreased. A good parallelism was found between resistance index and binding rate of the drug with cellular constituents when the intact cells were kept contacted in vitro with the drug in an incubation medium. When the cells were homogenized before contact with the drug, there was no difference in binding rate of the drug between sensitive and resistant cell lines. Suppression of cell membrane transport seemed to play a role in the acquisition of resistance by the cells.
π SIMILAR VOLUMES
## Abstract Sensitivity of Yoshida sarcoma lines resistant to nitrogen mustard (HN^2^) was not enhanced by pretreatment in vitro with SHβblocking agents such as 2,2β²βdithiodiβpyridine. This fact seems to indicate that content of cellular sulfhydryl groups did not play a great role in acquisition of
The Yoshida sarcoma and a line derived from it showing acquired resistance to alkylating agents have been compared from a number of aspects: chromosome number, growth rate, nucleic acid, protein and free thiol content. Although the degree of resistance to the alkylating agent Melphalan has been demo
## Abstract The concentration of ^3^Hβaniline mustard in two tumour lines has been measured and the level of binding of the drug to DNA followed for 48 hours after intraperitoneal injection. Although the two tumour lines differ a hundredβfold in their sensitivity to this alkylating agent, no good c